AI assistant
ABBOTT LABORATORIES — Director's Dealing 2017
Mar 2, 2017
29777_dirs_2017-03-02_e9b40067-f32c-464e-b545-015ccdc95e68.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-02-28
Reporting Person: Warmuth Michael J (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-28 | Common shares without par value | A | 26367 | — | Acquired | 69240 | Direct |
| 2017-02-28 | Common shares without par value | F | 8881 | $45.46 | Disposed | 60359 | Direct |
| 2017-03-01 | Common shares without par value | S | 3851 | $45.39 | Disposed | 56508 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 39413 | Indirect |
Footnotes
F1: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.
F2: Due to administrative error, the Form 4 previously filed on January 6, 2017 over-reported the shares acquired by 1 share. This Form 4 reflects the corrected total beneficial ownership for this reporting person.
F3: Held in the Stefanie M. Warmuth Revocable Trust. The reporting person and his spouse are trustees of the trust. The trust is revocable by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities.